Study #2020-0482
Pilot Study of Metabolic Guidance for Therapy in Patients with Thyroid Cancer and Other Malignancies of the Head and Neck
MD Anderson Study Status
Enrolling
Treatment Agent
Hyperpolarized Carbon C 13 Pyruvate
Description
This trial investigates whether hyperpolarized magnetic resonance imaging (hpMRI) can predict treatment response in patients with thyroid cancer and other malignancies of the head and neck undergoing radiation therapy and/or receiving systemic therapy before surgery. An hpMRI is like a standard MRI but involves the use of an imaging contrast agent called hyperpolarized 13-C-pyruvate. Diagnostic procedures, such as hpMRI, may predict a patient's response to treatment and may help plan the best treatment.
Resources and Links
Phone Number: 1-877-MDA-6789
Information and next steps
Disease:
Thyroid Gland Carcinoma
Study phase:
Phase I
Physician name:
Stephen Lai
Department:
Head & Neck Surgery
For general questions about clinical trials:
1-877-632-6789
Help #EndCancer
Give Now
Donate Blood
Our patients depend on blood and platelet donations.
Shop MD Anderson
Show your support for our mission through branded merchandise.